Zenas BioPharma sets price range for $200 million initial public offering

By / / Finance / 1 minute of reading



im 601020
Zenas BioPharma Inc., a Waltham, Mass.-based developer of immunology-based therapies, on Friday said it plans to offer 11.76 million shares of common stock at an estimated price range of $16 to $18 in its upcoming initial public offering.



Source link

About The Author

Avatar of Carole Jacobs
Carole Jacobs is a freelance writer and editor based in Phoenix, Arizona. She writes lifestyle, books, sports, education, and tech articles for a variety of publications and websites. Her hobbies include hiking, reading, and watching cat videos on YouTube.

Start typing and press enter to search

Scroll to Top